1. Home
  2. ONC vs MPWR Comparison

ONC vs MPWR Comparison

Compare ONC & MPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • MPWR
  • Stock Information
  • Founded
  • ONC 2010
  • MPWR 1997
  • Country
  • ONC Switzerland
  • MPWR United States
  • Employees
  • ONC N/A
  • MPWR N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • MPWR Semiconductors
  • Sector
  • ONC Health Care
  • MPWR Technology
  • Exchange
  • ONC Nasdaq
  • MPWR Nasdaq
  • Market Cap
  • ONC 37.2B
  • MPWR 38.6B
  • IPO Year
  • ONC N/A
  • MPWR 2004
  • Fundamental
  • Price
  • ONC $313.67
  • MPWR $844.00
  • Analyst Decision
  • ONC Strong Buy
  • MPWR Strong Buy
  • Analyst Count
  • ONC 9
  • MPWR 13
  • Target Price
  • ONC $335.78
  • MPWR $855.31
  • AVG Volume (30 Days)
  • ONC 410.3K
  • MPWR 701.6K
  • Earning Date
  • ONC 08-06-2025
  • MPWR 07-31-2025
  • Dividend Yield
  • ONC N/A
  • MPWR 0.74%
  • EPS Growth
  • ONC N/A
  • MPWR 358.16
  • EPS
  • ONC N/A
  • MPWR 38.48
  • Revenue
  • ONC $4,562,002,000.00
  • MPWR $2,543,912,000.00
  • Revenue This Year
  • ONC $865.19
  • MPWR $22.97
  • Revenue Next Year
  • ONC $21.12
  • MPWR $15.18
  • P/E Ratio
  • ONC N/A
  • MPWR $21.93
  • Revenue Growth
  • ONC 47.33
  • MPWR 34.30
  • 52 Week Low
  • ONC $170.99
  • MPWR $438.86
  • 52 Week High
  • ONC $330.63
  • MPWR $959.64
  • Technical
  • Relative Strength Index (RSI)
  • ONC 61.68
  • MPWR 61.19
  • Support Level
  • ONC $301.33
  • MPWR $805.94
  • Resistance Level
  • ONC $330.63
  • MPWR $868.00
  • Average True Range (ATR)
  • ONC 9.12
  • MPWR 30.23
  • MACD
  • ONC -0.19
  • MPWR -0.23
  • Stochastic Oscillator
  • ONC 66.43
  • MPWR 74.43

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

About MPWR Monolithic Power Systems Inc.

Monolithic Power Systems is an analog and mixed-signal chipmaker specializing in power management solutions. Its mission is to reduce total energy consumption in end systems. It serves the computing, automotive, industrial, communications, and consumer end markets. MPS uses a fabless manufacturing model, partnering with third-party chip foundries to host its proprietary BCD process technology.

Share on Social Networks: